ArticleThe Journal of infectious diseases2024

The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.

Karen Sauve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.